Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Mirati, Aadi To Evaluate Adagrasib, Nab-sirolimus Combination To Treat NSCLC, Other Solid Tumors

Por: RTTNews Health October 12, 2022

thumbnail

Oncology company Mirati Therapeutics, Inc. () and biopharmaceutical company Aadi Bioscience, Inc. () announced Wednesday a clinical collaboration to evaluate the combination of adagrasib, a KRASG12C selective inhibitor, and nab-sirolimus, a small molecule mTOR inhibitor complexed with human albumin in KRAS G12C mutant non-small cell lung cancer (NSCLC) and other solid tumors.The primary objective of this multi-center, single-arm, open-label... + full article



Similar News

Moderna and Merck will jointly develop a cancer vaccine for high-risk melanoma patients

CNBC USA Health October 12, 2022

thumbnailPipettes are seen at the Moderna Therapeutics Inc. lab in Cambridge, Massachusetts, U.S., on Tuesday, Nov. 14, 2017. Moderna this week started testingAdam Glanzman Bloomberg Getty Images and will jointly develop and sell a cancer vaccine that is personalized for individual... + más

Moderna surges as Merck ramps up collaboration on cancer vaccine | The Boston Globe

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate


Australia NAB Business Conditions Improve; Confidence Declines

RTTNews USA Business October 11, 2022

thumbnailAustralia's conditions improved on the back of very high trading conditions in September, while sentiment deteriorated notably, data from National Australia Bank showed Tuesday.The business conditions index rose three points to 25 in September. Meanwhile, the business... + más

Mirati, Aadi To Evaluate Adagrasib, Nab-sirolimus Combination To Treat NSCLC, Other Solid Tumors | RTTNews

Robust or vulnerable? Experts are split on Australia's economic outlook | CNBC


A Devious Cellular Trick Cancers Can Use to Escape Your Immune System

The New York Times USA Science September 29, 2022

thumbnailIn a surprise discovery, researchers found that cells from some types of cancers escaped destruction by the immune system by hiding inside other cancer cells.The finding, they suggested in published this month in the journal eLife, may explain why some cancers can be resistant... + más

Cancer in people under 50 is rising around the world. Why? | WGN-TV

What you need to know about 'original antigenic sin' with fall COVID boosters around the corner | ABC News


A New Approach to Spotting Tumors: Look for Their Microbes

The New York Times USA Science September 29, 2022

thumbnailLook up an image of a tumor on Google, and you’ll probably end up with a brightly colored cluster of cancer cells on a drab background of healthy tissue. But for Lian Narunsky Haziza, a cancer biologist at the Weizmann Institute of Science in Israel, the picture looks very... + más

A Devious Cellular Trick Cancers Can Use to Escape Your Immune System | The New York Times

Should We Be Searching for Smart Aliens or Dumb Aliens? | The Atlantic


Study investigates impact of radiation on pediatric brain tumors

WPLG Local 10 USA Health September 24, 2022

thumbnailKENDALL, Fla. – A study is underway in South Florida that researchers hope will improve radiation treatment for children and young adults with brain tumors.The investigation at Baptist Health’s Miami Cancer Institute is looking at ways to optimize outcomes and reduce risks... + más

A New Approach to Spotting Tumors: Look for Their Microbes | The New York Times

Chernobyl radiation caused frogs to genetically mutate, turning black | Newsweek


Will Fennec's Pedmark Cross FDA Finish Line This Time?

RTTNews USA Health September 24, 2022

thumbnailFennec Pharmaceuticals Inc. (), a specialty pharmaceutical company, anticipates FDA decision on its investigational drug PEDMARK, proposed for the prevention of platinum-induced ototoxicity in pediatric patients one month to less than 18 years of age with localized,... + más

ALS drug wins FDA approval despite questionable data | ABC News

ALS drug wins FDA approval despite questionable data | WPLG Local 10


Chinese firm claims it has cloned an Arctic wolf, made it live with a dog

Newsweek USA Tech September 24, 2022

thumbnailScientists in China say they have managed to clone an Arctic wolf using a controversial method that some say could save species from extinction in the future.The cloned wolf was announced by Beijing-based company Sinogene Biotechnology on September 19, 100 days after it was born... + más

They Cloned Tyrone’s onto something wild in its first trailer | The Verge

When dog-sitting for an ex gets too complicated | The Boston Globe



About iurex | Privacy Policy | Disclaimer |